Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection

BMC Immunology

Volumn 15, Issue 1, 2014, Pages

  Foronjy, Robert F ^a   Dabo, Abdoulaye J ^a   Cummins, Neville ^a   Geraghty, Patrick ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Gene expression; Immune response; Pathogen recognition receptors; Respiratory syncytial virus

Indexed keywords

CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; LGP2 PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; MIGRATION INHIBITION FACTOR; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; STEM CELL FACTOR; STEM CELL GROWTH FACTOR BETA; STROMAL CELL DERIVED FACTOR 1; TIR DOMAIN CONTAINING ADAPTER INDUCING INTERFERON BETA; UNCLASSIFIED DRUG; CYTOKINE; IPS-1 PROTEIN, MOUSE; LIF PROTEIN, HUMAN; LIF PROTEIN, MOUSE; PROTECTIVE AGENT; RETINOIC ACID RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TICAM-1 PROTEIN, MOUSE; TOLL LIKE RECEPTOR; VESICULAR TRANSPORT ADAPTOR PROTEIN;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENE SILENCING; GENETICS; HUMAN; HUMAN CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IN VIVO STUDY; LUNG INJURY; LUNG PROTECTION; MOUSE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PROTECTION; PROTEIN CONTENT; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT ALLERGY; SMALL AIRWAY EPITHELIAL CELL; VIRUS REPLICATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; DEFICIENCY; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; METABOLISM; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SERODIAGNOSIS; VIROLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CYTOKINES; EPITHELIAL CELLS; GENE SILENCING; HUMANS; LEUKEMIA INHIBITORY FACTOR; LUNG; MICE, KNOCKOUT; NEUTRALIZATION TESTS; PROTECTIVE AGENTS; RECEPTORS, RETINOIC ACID; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TOLL-LIKE RECEPTORS;

EID: 84949116015     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/s12865-014-0041-4     Document Type: Article

References (69)

1. Guo-Parke H, Canning P, Douglas I, Villenave R, Heaney LG, Coyle PV, Lyons JD, Shields MD, Power UF: Relative Respiratory Syncytial Virus Cytopathogenesis in Upper and Lower Respiratory Tract Epithelium. Am J Respir Crit Care Med 2013, 188(7):842-851.
2. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE: Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005, 352(17):1749-1759.
3. Respiratory syncytial virus activity-United States, 2003-2004. MMWR Morb Mortal Wkly Rep 2004, 53(49):1159-1160
4. Hacking D, Hull J: Respiratory syncytial virus-viral biology and the host response. J Infect 2002, 45(1):18-24.
5. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, Kjellman B: Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005, 171(2):137-141.
6. Sajjan US: Susceptibility to viral infections in chronic obstructive pulmonary disease: role of epithelial cells. Curr Opin Pulm Med 2013, 19(2):125-132.
7. Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS, Becker S: Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995, 171(3):584-592.
8. Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, Sanchez PJ, Ramilo O: Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999, 18(2):115-122.
9. Abu-Harb M, Bell F, Finn A, Rao WH, Nixon L, Shale D, Everard ML: IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur Respir J 1999, 14(1):139-143.
10. Tabarani CM, Bonville CA, Suryadevara M, Branigan P, Wang D, Huang D: Rosenberg HF. Novel Inflammatory Markers, Clinical Risk Factors, and Virus Type Associated with Severe Respiratory Syncytial Virus Infection. Pediatr Infect Dis J: Domachowske JB; 2013.
11. Arnold R, Humbert B, Werchau H, Gallati H, Konig W: Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 1994, 82(1):126-133.
12. Zdrenghea MT, Telcian AG, Laza-Stanca V, Bellettato CM, Edwards MR, Nikonova A, Khaitov MR, Azimi N, Groh V, Mallia P, Johnston SL, Stanciu LA: RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells. Eur Respir J 2012, 39(3):712-720.
13. Zhang Y, Luxon BA, Casola A, Garofalo RP, Jamaluddin M, Brasier AR: Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol 2001, 75(19):9044-9058.
14. Dosanjh A, Rednam S, Martin M: Respiratory syncytial virus augments production of fibroblast growth factor basic in vitro: implications for a possible mechanism of prolonged wheezing after infection. Pediatr Allergy Immunol 2003, 14(6):437-440.
15. Brand HK, Ferwerda G, Preijers F, de Groot R, Neeleman C, Staal FJ, Warris A, Hermans PW: CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection. Pediatr Res 2013, 73(2):187-193.
16. Kim CK, Callaway Z, Koh YY, Kim SH, Fujisawa T: Airway IFN-gamma production during RSV bronchiolitis is associated with eosinophilic inflammation. Lung 2012, 190(2):183-188.
17. Ermers MJ, Janssen R, Onland-Moret NC, Hodemaekers HM, Rovers MM, Houben ML, Kimpen JL, Bont LJ: IL10 family member genes IL19 and IL20 are associated with recurrent wheeze after respiratory syncytial virus bronchiolitis. Pediatr Res 2011, 70(5):518-523.
18. Wright C, Oliver KC, Fenwick FI, Smith NM, Toms GL: A monoclonal antibody pool for routine immunohistochemical detection of human respiratory syncytial virus antigens in formalin-fixed, paraffin-embedded tissue. J Pathol 1997, 182(2):238-244.
19. McGill JL, Nonnecke BJ, Lippolis JD, Reinhardt TA, Sacco RE: Differential chemokine and cytokine production by neonatal bovine gammadelta T-cell subsets in response to viral toll-like receptor agonists and in vivo respiratory syncytial virus infection. Immunology 2013, 139(2):227-244.
20. Kimura H, Yoshizumi M, Ishii H, Oishi K, Ryo A: Cytokine production and signaling pathways in respiratory virus infection. Front Microbiol 2013, 4:276.
21. Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, Enelow R, Elias JA: Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest 2008, 118(8):2771-2784.
22. Slater L, Bartlett NW, Haas JJ, Zhu J, Message SD, Walton RP, Sykes A, Dahdaleh S, Clarke DL, Belvisi MG, Kon OM, Fujita T, Jeffery PK, Johnston SL, Edwards MR: Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog 2010, 6(11):e1001178.
23. Scagnolari C, Midulla F, Pierangeli A, Moretti C, Bonci E, Berardi R, De Angelis D, Selvaggi C, Di Marco P, Girardi E, Antonelli G: Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis. Clin Vaccine Immunol 2009, 16(6):816-823.
24. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000, 1(5):398-401.
25. Sasai M, Shingai M, Funami K, Yoneyama M, Fujita T, Matsumoto M, Seya T: NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J Immunol 2006, 177(12):8676-8683.
26. Shafique M, Meijerhof T, Wilschut J, de Haan A: Evaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses. PLoS One 2013, 8(4):e61287.
27. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, Gough NM: Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988, 336(6200):684-687.
28. Jorens PG, De Jongh R, Bossaert LL, De Backer W, Herman AG, Pollet H, Bosmans E, Taupin JL, Moreau JF: High levels of leukaemia inhibitory factor in ARDS. Cytokine 1996, 8(11):873-876.
29. Quinton LJ, Mizgerd JP, Hilliard KL, Jones MR, Kwon CY, Allen E: Leukemia inhibitory factor signaling is required for lung protection during pneumonia. J Immunol 2012, 188(12):6300-6308.
30. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M Jr: Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008, 82(1):335-345.
31. Lay MK, Gonzalez PA, Leon MA, Cespedes PF, Bueno SM, Riedel CA, Kalergis AM: Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response. Microbes Infect 2013, 15(3):230-242.
32. Ulich TR, Fann MJ, Patterson PH, Williams JH, Samal B, Del Castillo J, Yin S, Guo K, Remick DG: Intratracheal injection of LPS and cytokines. V LPS induces expression of LIF and LIF inhibits acute inflammation Am J Physiol 1994, 267(4 Pt 1):L442-L446.
33. Wang J, Chen Q, Corne J, Zhu Z, Lee CG, Bhandari V, Homer RJ, Elias JA: Pulmonary expression of leukemia inhibitory factor induces B cell hyperplasia and confers protection in hyperoxia. J Biol Chem 2003, 278(33):31226-31232.
34. Tripp RA, Oshansky C, Alvarez R: Cytokines and respiratory syncytial virus infection. Proc Am Thorac Soc 2005, 2(2):147-149.
35. Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, Yusuf M, Kapur P, Hardy RD, Hatfield J, Rogers BB, Krisher K, Ramilo O: Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 2004, 189(10):1856-1865.
36. McNamara PS, Flanagan BF, Hart CA, Smyth RL: Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2005, 191(8):1225-1232.
37. Bach JP, Rinn B, Meyer B, Dodel R, Bacher M: Role of MIF in inflammation and tumorigenesis. Oncology 2008, 75(3-4):127-133.
38. Chen L, Lin SX, Agha-Majzoub R, Overbergh L, Mathieu C, Chan LS: CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model. Int Immunol 2006, 18(8):1233-1242.
39. Qiu L, Huang D, Chen CY, Wang R, Shen L, Shen Y, Hunt R, Estep J, Haynes BF, Jacobs WR Jr, Letvin N, Du G, Chen ZW: Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis 2008, 198(10):1514-1519.
40. Elliott MB, Tebbey PW, Pryharski KS, Scheuer CA, Laughlin TS, Hancock GE: Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5). J Med Virol 2004, 73(2):300-308.
41. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA: A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996, 184(3):1101-1109.
42. Makino H, Aono Y, Azuma M, Kishi M, Yokota Y, Kinoshita K, Takezaki A, Kishi J, Kawano H, Ogawa H, Uehara H, Izumi K, Sone S, Nishioka Y: Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice. J Med Invest 2013, 60(1-2):127-137.
43. Hiraoka A, Yano Ki K, Kagami N, Takeshige K, Mio H, Anazawa H, Sugimoto S: Stem cell growth factor: in situ hybridization analysis on the gene expression, molecular characterization and in vitro proliferative activity of a recombinant preparation on primitive hematopoietic progenitor cells. Hematol J 2001, 2(5):307-315.
44. Makowska JS, Cieslak M, Kowalski ML: Stem cell factor and its soluble receptor (c-kit) in serum of asthmatic patients- correlation with disease severity. BMC Pulm Med 2009, 9:27.
45. Linker RA, Kruse N, Israel S, Wei T, Seubert S, Hombach A, Holtmann B, Luhder F, Ransohoff RM, Sendtner M, Gold R: Leukemia inhibitory factor deficiency modulates the immune response and limits autoimmune demyelination: a new role for neurotrophic cytokines in neuroinflammation. J Immunol 2008, 180(4):2204-2213.
46. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA: Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol 2000, 22(5):535-542.
47. Waxman AB, Einarsson O, Seres T, Knickelbein RG, Warshaw JB, Johnston R, Homer RJ, Elias JA: Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J Clin Invest 1998, 101(9):1970-1982.
48. Kamohara H, Sakamoto K, Ishiko T, Masuda Y, Abe T, Ogawa M: Leukemia inhibitory factor induces apoptosis and proliferation of human carcinoma cells through different oncogene pathways. Int J Cancer 1997, 72(4):687-695.
49. Schere-Levy C, Buggiano V, Quaglino A, Gattelli A, Cirio MC, Piazzon I, Vanzulli S, Kordon EC: Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Exp Cell Res 2003, 282(1):35-47.
50. Furue M, Okamoto T, Hayashi Y, Okochi H, Fujimoto M, Myoishi Y, Abe T, Ohnuma K, Sato GH, Asashima M, Sato JD: Leukemia inhibitory factor as an anti-apoptotic mitogen for pluripotent mouse embryonic stem cells in a serum-free medium without feeder cells. In Vitro Cell Dev Biol Anim 2005, 41(1-2):19-28.
51. Lu Y, Fukuyama S, Yoshida R, Kobayashi T, Saeki K, Shiraishi H, Yoshimura A, Takaesu G: Loss of SOCS3 gene expression converts STAT3 function from anti-apoptotic to pro-apoptotic. J Biol Chem 2006, 281(48):36683-36690.
52. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB: Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989, 140(6):1745-1753.
53. Hogan BL, Barkauskas CE, Chapman HA, Epstein JA, Jain R, Hsia CC, Niklason L, Calle E, Le A, Randell SH, Rock J, Snitow M, Krummel M, Stripp BR, Vu T, White ES, Whitsett JA, Morrisey EE: Repair and Regeneration of the Respiratory System: Complexity, Plasticity, and Mechanisms of Lung Stem Cell Function. Cell Stem Cell 2014, 15(2):123-138.
54. Tadokoro T, Wang Y, Barak LS, Bai Y, Randell SH, Hogan BL: IL-6/STAT3 promotes regeneration of airway ciliated cells from basal stem cells. Proc Natl Acad Sci U S A 2014, 111(35):E3641-E3649.
55. Manuse MJ, Parks GD: TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5. Virology 2010, 397(1):231-241.
56. Lukacs NW, Smit JJ, Mukherjee S, Morris SB, Nunez G, Lindell DM: Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J Immunol 2010, 185(4):2231-2239.
57. Rudd BD, Burstein E, Duckett CS, Li X, Lukacs NW: Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 2005, 79(6):3350-3357.
58. Bhoj VG, Sun Q, Bhoj EJ, Somers C, Chen X, Torres JP, Mejias A, Gomez AM, Jafri H, Ramilo O, Chen ZJ: MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus. Proc Natl Acad Sci U S A 2008, 105(37):14046-14051.
59. Sun Q, Sun L, Liu HH, Chen X, Seth RB, Forman J, Chen ZJ: The specific and essential role of MAVS in antiviral innate immune responses. Immunity 2006, 24(5):633-642.
60. Martinez-Gil L, Goff PH, Hai R, Garcia-Sastre A, Shaw ML, Palese P: A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant. J Virol 2013, 87(3):1290-1300.
61. Rehwinkel J, Tan CP, Goubau D, Schulz O, Pichlmair A, Bier K, Robb N, Vreede F, Barclay W, Fodor E, Reis e Sousa C: RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140(3):397-408.
62. Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, Barchet W, Coch C, Janke M, Mihailovic A, Wardle G, Juranek S, Kato H, Kawai T, Poeck H, Fitzgerald KA, Takeuchi O, Akira S, Tuschl T, Latz E, Ludwig J, Hartmann G: Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31(1):25-34.
63. Boyapalle S, Wong T, Garay J, Teng M, San Juan-Vergara H, Mohapatra S: Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection. PLoS One 2012, 7(2):e29386.
64. Ling Z, Tran KC, Teng MN: Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J Virol 2009, 83(8):3734-3742.
65. Liu P, Jamaluddin M, Li K, Garofalo RP, Casola A, Brasier AR: Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol 2007, 81(3):1401-1411.
66. Villenave R, Thavagnanam S, Sarlang S, Parker J, Douglas I, Skibinski G, Heaney LG, McKaigue JP, Coyle PV, Shields MD, Power UF: In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo. Proc Natl Acad Sci U S A 2012, 109(13):5040-5045.
67. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ: Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 2002, 76(11):5654-5666.
68. Boukhvalova MS, Yim KC, Prince GA, Blanco JC: Methods for monitoring dynamics of pulmonary RSV replication by viral culture and by real-time reverse transcription-PCR in vivo: Detection of abortive viral replication. Curr Protoc Cell Biol 2010, Chapter 26:26. Unit26.
69. Foronjy RF, Taggart CC, Dabo AJ, Weldon S, Cummins N, Geraghty P: Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors. Mucosal Immunol 2014, [Epud ahead of print].